Provided by Tiger Trade Technology Pte. Ltd.

Amneal Pharmaceuticals, Inc.

11.85
-0.2100-1.74%
Post-market: 11.850.00000.00%17:20 EDT
Volume:1.15M
Turnover:13.65M
Market Cap:3.78B
PE:53.86
High:12.11
Open:12.01
Low:11.83
Close:12.06
52wk High:15.42
52wk Low:6.69
Shares:319.00M
Float Shares:191.00M
Volume Ratio:0.42
T/O Rate:0.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.2200
EPS(LYR):0.2200
ROE:-881.26%
ROA:7.32%
PB:-53.40
PE(LYR):53.86

Loading ...

Amneal Pharmaceuticals Outlook FY Adjusted Ebitda USD 720-760 Million

THOMSON REUTERS
·
Feb 27

Amneal Pharmaceuticals Q4 Pretax Profit USD 55.235 Million

THOMSON REUTERS
·
Feb 27

Amneal Reports Fourth Quarter and Full Year 2025 Financial Results

THOMSON REUTERS
·
Feb 27

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Feb 27

U.S. Earnings Preview: Before Market Open Feb. 27

Dow Jones
·
Feb 27

Earning Preview: Amneal Pharmaceuticals, Inc. Q1 revenue is expected to increase by 14.18%, and institutional views are constructive

Earnings Agent
·
Feb 20

BRIEF-Amneal Pharma Says On Feb 2nd, Co Enters Amendment No. 2 To Term Loan Credit Agreement - SEC Filing

Reuters
·
Feb 03

Amneal Pharma: Amneal Pharma - Consenting Lenders Converted Existing Term Loans Into New Term Loans With an Amount of $1.96 Bln-SEC Filing

THOMSON REUTERS
·
Feb 03

Amneal Pharma - on Feb 2Nd, Co Enters Amendment No. 2 to Term Loan Credit Agreement - SEC Filing

THOMSON REUTERS
·
Feb 03

Amneal Pharmaceuticals senkt Zinsmarge bei bestehendem Terminkredit um 50 Basispunkte

Reuters
·
Feb 03

BRIEF-Amneal Pharma To Settle Majority Of Opioids-Related Claims

Reuters
·
Jan 29

Amneal Pharmaceuticals Settles Opioid Lawsuits for $88.5 Million and Naloxone Donations

Reuters
·
Jan 29

Amneal Pharma - to Provide $177.4 Mln in Naloxone Nasal Spray to Help Treat Opioid Overdoses - SEC Filing

THOMSON REUTERS
·
Jan 29

Amneal Pharma - to Pay $88.5 Mln Under Opioids Settlement - SEC Filing

THOMSON REUTERS
·
Jan 29

BUZZ-Amneal Pharma gains as co poised to join S&P SmallCap index

Reuters
·
Jan 28

Amneal to Report Fourth Quarter and Full Year 2025 Results on February 27, 2026

GlobeNewswire
·
Jan 27

Assessing Amneal Pharmaceuticals (AMRX) Valuation After Recent Share Price Momentum

Simply Wall St.
·
Jan 22

Amneal Pharma: Expects to Meet or Exceed Its 2025 Full-Year Financial Guidance

THOMSON REUTERS
·
Jan 13

Amneal Pharmaceuticals Inc FY2025 Shr View $0.80, REV View $3.01 Bln -- Lseg Ibes Data

THOMSON REUTERS
·
Jan 13

Amneal Pharmaceuticals Expects to Meet or Exceed 2025 Financial Guidance

Reuters
·
Jan 13